⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

Elixiron Immunotherapeutics (Taiwan)

h-index: 4
Total citations: 178
Total papers: 15

Homepage: http://www.elixiron.com/

Recent papers from Elixiron Immunotherapeutics (Taiwan)

Chimeric autoantibody receptor T cells clonally eliminate B cells producing autoantibodies against IFN-γScience Immunology · 2025
PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver MetastasisCancer Discovery · 2025
Abstract 2370: Revitalizing anti-tumor immunity through PLT012 monoclonal antibody, targeting CD36 for metabolic rewiring in the tumor microenvironmentCancer Research · 2024
A CSF-1R-blocking antibody/IL-10 fusion protein increases anti-tumor immunity by effectuating tumor-resident CD8+ T cellsCell Reports Medicine · 2023
Pathogenic autoantibodies to IFN-γ act through the impedance of receptor assembly and Fc-mediated responseThe Journal of Experimental Medicine · 2022
Skin Interstitial Fluid and Plasma Multiplex Cytokine Analysis Reveals IFN-γ Signatures and Granzyme B as Useful Biomarker for Activity, Severity and Prognosis Assessment in VitiligoFrontiers in Immunology · 2022
Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonizationNature Communications · 2018